Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators

Item

http://www.wikidata.org/entity/Q33975889

Q33975889

about

Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.Lack of pharmacokinetic interaction between amdoxovir and reduced- and standard-dose zidovudine in HIV-1-infected individuals.Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics.Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected Thai patients receiving indinavir boosted with ritonavir.Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.Lopinavir/Ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapy.Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals.Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients.Evaluation of antiretroviral therapy results in Blantyre, Malawi.Nevirapine exposure with WHO pediatric weight band dosing: enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experience.Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women Pharmacokinetics of phase I nevirapine metabolites following a single dose and at steady state.Clinical pharmacokinetics of antiretroviral drugs in older persons.Development of an optimized dose for coformulation of zidovudine with drugs that select for the K65R mutation using a population pharmacokinetic and enzyme kinetic simulation model.Caring for women living with HIV: gaps in the evidence.Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.Population pharmacokinetics study of recommended zidovudine doses in HIV-1-infected children Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis.Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children.Clinical and genetic determinants of nevirapine plasma trough concentration.

P2860

Q24602072-C8E760B0-47C4-43A9-9E7D-B368F586BE94 Q33459535-8036852D-A64C-4F1A-BB14-10F24FAE4589 Q33676340-13153861-521E-4A4B-BFBC-02A653BDE11F Q34149022-C628D654-57C9-4790-B2D3-FD87AECB3AF6 Q34677780-5B7EB8EE-0A4F-4830-8D7C-0ABB44C3E0C8 Q34732899-F98B6221-ECC2-4F3F-8E39-D629E074A16A Q34776414-6F590E66-2599-4F7D-AF5F-A01B6A597ABB Q35804046-D1332F9F-EEEB-4904-844E-6BDE9195F15D Q35826691-AFAA45EF-6CBC-40BC-8E53-195358773F98 Q35937624-A1B09627-5714-4434-9AD4-9AD035EAB4A9 Q36276839-FFEDC2F2-F67D-4C76-92AE-1D33BE18F51F Q36422444-ADD47F42-ACD7-4B58-9B5C-81912D4AB1CB Q36785839-A16589A2-DA2D-4B28-8F0F-9657EC8681BD Q36905884-0D6C4E8C-FB30-41E8-8902-76C0404CF2EF Q36993425-C908BB06-69B2-4458-9CFA-A940245B2CCB Q37212049-234C03F4-96A9-4EDA-9DC8-B3C6EDC6A880 Q37245017-D9911F36-D7AF-4E30-9FA3-3575D23CEFE8 Q37263890-977F5C86-BC37-414E-9372-267D99EF8EA0 Q37361810-FBC4F264-66A9-4119-9CF1-8430D49E5DCC Q37509532-2FED48A3-F33C-4F45-93AD-F582EF542BF3 Q55263551-AA4E5FD4-C158-4EED-85B3-0BB8F6356842

P2860

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators

Item

http://www.wikidata.org/entity/Q33975889

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu